Cargando…

AB019. Long-term outcomes of urethroplasty with heterogeneous acellular dermal matrix: a five-case series

BACKGROUND: This study aimed to evaluate the long-term results of heterogeneous acellular dermal matrix (HADM) as a scaffold for urethral stricture repair. HADM is commercially available and widely used in plastic surgery, but rarely applied to urethral reconstruction. METHODS: Five patients with a...

Descripción completa

Detalles Bibliográficos
Autor principal: Lin, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186728/
http://dx.doi.org/10.21037/tau.2018.AB019
_version_ 1783362890375364608
author Lin, Jian
author_facet Lin, Jian
author_sort Lin, Jian
collection PubMed
description BACKGROUND: This study aimed to evaluate the long-term results of heterogeneous acellular dermal matrix (HADM) as a scaffold for urethral stricture repair. HADM is commercially available and widely used in plastic surgery, but rarely applied to urethral reconstruction. METHODS: Five patients with a diagnosis of recurrent urethral stricture were enrolled at the Peking University First Hospital and underwent urethroplasty using HADM. Two patients had a membranous stricture, and three had a penile stricture. All patients had previous surgical interventions. The repair technique was determined during the surgery. HADM was used as a tubularized substitution in three patients, and an onlay patch augmentation was performed in the other two patients. Each patient had an 18F catheter left in place for 6 months. Uroflowmetry was performed routinely after surgery, and the outcome was considered as a failure when the maximal flow rate was less than 14 mL/s. RESULTS: The mean urinary flow rate before surgery was 0 mL/s due to the severe stricture obstruction preoperatively. Postoperatively, the median maximal flow rate was 21.5 mL/s (n=5). The median maximal flow rate was 13.85 mL/s (n=4) after 5 years. In fact, two patients had to undergo another or a third surgery to help urination during the follow-up, and only one patient could retain a maximal flow rate of more than 14 mL/s 5 years after the surgery. CONCLUSIONS: The use of HADM to repair the urethral stricture in the patients was not satisfactory probably because of the poor urethra bed quality.
format Online
Article
Text
id pubmed-6186728
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-61867282018-10-26 AB019. Long-term outcomes of urethroplasty with heterogeneous acellular dermal matrix: a five-case series Lin, Jian Transl Androl Urol Podium Lecture BACKGROUND: This study aimed to evaluate the long-term results of heterogeneous acellular dermal matrix (HADM) as a scaffold for urethral stricture repair. HADM is commercially available and widely used in plastic surgery, but rarely applied to urethral reconstruction. METHODS: Five patients with a diagnosis of recurrent urethral stricture were enrolled at the Peking University First Hospital and underwent urethroplasty using HADM. Two patients had a membranous stricture, and three had a penile stricture. All patients had previous surgical interventions. The repair technique was determined during the surgery. HADM was used as a tubularized substitution in three patients, and an onlay patch augmentation was performed in the other two patients. Each patient had an 18F catheter left in place for 6 months. Uroflowmetry was performed routinely after surgery, and the outcome was considered as a failure when the maximal flow rate was less than 14 mL/s. RESULTS: The mean urinary flow rate before surgery was 0 mL/s due to the severe stricture obstruction preoperatively. Postoperatively, the median maximal flow rate was 21.5 mL/s (n=5). The median maximal flow rate was 13.85 mL/s (n=4) after 5 years. In fact, two patients had to undergo another or a third surgery to help urination during the follow-up, and only one patient could retain a maximal flow rate of more than 14 mL/s 5 years after the surgery. CONCLUSIONS: The use of HADM to repair the urethral stricture in the patients was not satisfactory probably because of the poor urethra bed quality. AME Publishing Company 2018-09 /pmc/articles/PMC6186728/ http://dx.doi.org/10.21037/tau.2018.AB019 Text en 2018 Translational Andrology and Urology. All rights reserved.
spellingShingle Podium Lecture
Lin, Jian
AB019. Long-term outcomes of urethroplasty with heterogeneous acellular dermal matrix: a five-case series
title AB019. Long-term outcomes of urethroplasty with heterogeneous acellular dermal matrix: a five-case series
title_full AB019. Long-term outcomes of urethroplasty with heterogeneous acellular dermal matrix: a five-case series
title_fullStr AB019. Long-term outcomes of urethroplasty with heterogeneous acellular dermal matrix: a five-case series
title_full_unstemmed AB019. Long-term outcomes of urethroplasty with heterogeneous acellular dermal matrix: a five-case series
title_short AB019. Long-term outcomes of urethroplasty with heterogeneous acellular dermal matrix: a five-case series
title_sort ab019. long-term outcomes of urethroplasty with heterogeneous acellular dermal matrix: a five-case series
topic Podium Lecture
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186728/
http://dx.doi.org/10.21037/tau.2018.AB019
work_keys_str_mv AT linjian ab019longtermoutcomesofurethroplastywithheterogeneousacellulardermalmatrixafivecaseseries